Truepoint, Inc. - AERPIO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Truepoint, Inc. ownership history of AERPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$010,2190.0%0.00%
Q4 2021$0
-100.0%
10,2190.0%0.00%
-100.0%
Q3 2021$22,000
+29.4%
10,2190.0%0.00%0.0%
Q2 2021$17,000
+30.8%
10,2190.0%0.00%0.0%
Q1 2021$13,000
+30.0%
10,2190.0%0.00%0.0%
Q4 2020$10,000
+66.7%
10,2190.0%0.00%
Q4 2019$6,000
-14.3%
10,2190.0%0.00%
-100.0%
Q3 2019$7,000
-22.2%
10,2190.0%0.00%0.0%
Q2 2019$9,0000.0%10,2190.0%0.00%0.0%
Q1 2019$9,000
-47.1%
10,2190.0%0.00%
-50.0%
Q4 2018$17,000
-46.9%
10,2190.0%0.00%
-33.3%
Q3 2018$32,000
-23.8%
10,2190.0%0.00%
-25.0%
Q2 2018$42,00010,2190.00%
Other shareholders
AERPIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 5,621,835$7,252,0003.21%
Parkman Healthcare Partners LLC 1,001,189$1,292,0000.30%
ABG Innovation Capital Partners III GP Ltd 400,000$516,0000.25%
Opaleye Management Inc. 1,000,000$1,290,0000.19%
EcoR1 Capital, LLC 2,072,782$2,674,0000.12%
Ikarian Capital, LLC 2,651,093$3,420,0000.12%
Scion Asset Management 1,000,000$1,290,0000.10%
Orbimed Advisors 5,193,946$6,700,0000.06%
Keudell/Morrison Wealth Management 30,694$40,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 302,949$391,0000.02%
View complete list of AERPIO PHARMACEUTICALS INC shareholders